MORGAN STANLEY - AVENUE THERAPEUTICS INC ownership

AVENUE THERAPEUTICS INC's ticker is and the CUSIP is 05360L304. A total of 14 filers reported holding AVENUE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of AVENUE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$195
-59.7%
276
-33.3%
0.00%
Q2 2023$484
+0.4%
4140.0%0.00%
Q1 2023$482
-87.5%
414
-87.6%
0.00%
Q4 2022$3,865
-74.2%
3,332
+126.1%
0.00%
Q3 2022$15,0001,4740.00%
Other shareholders
AVENUE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
EMFO, LLC 533$5,0000.01%
TWO SIGMA SECURITIES, LLC 14,159$143,0000.00%
TWO SIGMA INVESTMENTS, LP 14,342$145,0000.00%
BANK OF AMERICA CORP /DE/ 1$00.00%
WELLS FARGO & COMPANY/MN 4,538$46,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
CITIGROUP INC 510$5,0000.00%
MORGAN STANLEY 1,474$15,0000.00%
BlackRock Inc. 1,941$20,0000.00%
Citadel Advisors 35,865$362,0000.00%
View complete list of AVENUE THERAPEUTICS INC shareholders